The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials
Abstract The novel coronavirus outbreak began in late December 2019 and rapidly spread worldwide, critically impacting public health systems. A number of already approved and marketed drugs are being tested for repurposing, including Favipiravir. We aim to investigate the efficacy and safety of Favi...
Main Authors: | Soheil Hassanipour, Morteza Arab-Zozani, Bahman Amani, Forough Heidarzad, Mohammad Fathalipour, Rudolph Martinez-de-Hoyo |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-05-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-90551-6 |
Similar Items
-
Favipiravir for treating patients with novel coronavirus (COVID-19): protocol for a systematic review and meta-analysis of randomised clinical trials
by: Morteza Arab-Zozani, et al.
Published: (2020-07-01) -
Evaluation of the efficacy and safety of favipiravir and interferon compared to lopinavir/ritonavir and interferon in moderately ill patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial
by: Mehdi Hassaniazad, et al.
Published: (2020-10-01) -
Safety and effectiveness of favipiravir for novel coronavirus (COVID-19): a rapid review of available evidence
by: Mohammad reza Mobinizadeh, et al.
Published: (2020-10-01) -
The efficacy and safety of interferons for the treatment of patients with COVID-19: protocol for systematic review and meta-analysis of controlled trials
by: Afsaneh Noormandi, et al.
Published: (2021-06-01) -
Features and Limitations of LitCovid Hub for Quick Access to Literature About COVID-19
by: Morteza Arab-Zozani, et al.
Published: (2020-07-01)